{
  "report_rows": [
    {
      "kpi": "CC ARR ex-divested (Q3 FY26)",
      "prediction": "IN-LINE",
      "answer": "pred ~$2,445M vs. cons $2,436M",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Net New ARR (Q3 FY26)",
      "prediction": "BEAT",
      "answer": "pred ~$52M vs. cons $47.9M",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Non-GAAP EPS (Q3 FY26)",
      "prediction": "BEAT",
      "answer": "pred ~$1.75 vs. cons $1.54",
      "confidence": "HIGH"
    }
  ],
  "guide_rows": [
    {
      "kpi": "CC ARR growth (FY26)",
      "prediction": "UNCHANGED",
      "answer": "guide 7.5-9.5% maintained vs. cons $2,519M",
      "confidence": "HIGH"
    },
    {
      "kpi": "Non-GAAP EPS (FY26)",
      "prediction": "BETTER",
      "answer": "guide ~$6.90-$9.10 vs. cons $7.95",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FCF (FY26)",
      "prediction": "UNCHANGED",
      "answer": "guide ~$850M maintained vs. cons $852M",
      "confidence": "HIGH"
    }
  ],
  "day1_residual_pct": -1.5,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": -3.5,
  "day5_path": "FADE",
  "day5_rationale": "FADE \u2014 FY26 ARR guide unchanged suppresses estimate revisions; pre-print +13.5% run unwinds; EPS beat likely duration-driven (non-recurring), same dynamic as May 6 quarter which faded -7.2% over 5 days",
  "day5_confidence": "MEDIUM"
}